18 Apr 2024

Press & news

FluoGuide develops surgical solutions that is expected to reduce suffering for the patient and increases the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

FluoGuide convenes an extraordinary general meeting


July 7, 2023

Copenhagen, Denmark, 7 July 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) hereby invites shareholders to participate in an extraordinary general meeting to be held on 25 July 2023 at 11 AM CEST on Ole Maaløes Vej 3, DK-2200 Copenhagen N, Denmark.

To the shareholders of FluoGuide A/S

In continuance of the published press release regarding the Company’s completion of a Directed Issue, the Company has to obtain an authorisation to issue warrants to the investors. The board of directors thus proposes that in addition to the subscription of shares, the investors participating in the Directed Share Issue, cf. press release regarding Directed Share Issue of 5 July 2023, should receive in aggregate 211,389 warrants, that each confer the right to subscribe nominal DKK 0.1 share.

The issuance of warrants is subject to the board of directors obtaining an authorization from the general meeting to issue the warrants and consequently the board of directors hereby convenes an extraordinary general meeting in FluoGuide in order to seek to obtain such authorisation. The extraordinary general meeting will be held on:

Tuesday 25 July 2023 at 11:00 (CEST)
at the Company’s premises, Ole Maaløes Vej 3, room M0.10 – Neon, DK-2200 Copenhagen N, Denmark.

Please find the convening notice attached this press release. The convening notice can also be found on the Company’s website: